Disc Medicine, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Disc Medicine, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Disc Medicine, Inc. Return On Equity for the quarter ending September 30, 2024 was -25.2 %, a 12.2% decline year-over-year.
  • Disc Medicine, Inc. annual Return On Equity for 2023 was -23.4 %, a 110% decline from 2022.
  • Disc Medicine, Inc. annual Return On Equity for 2022 was 239 %.
  • Disc Medicine, Inc. annual Return On Equity for 2021 was -35.5 %, a 109% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -25.2 -2.74 -12.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -23.8 +15 +38.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -22.8 +82 +78.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -23.4 -262 -110% Oct 1, 2023 Dec 31, 2023
Q3 2023 -22.5 -44.4 -203% Jul 1, 2023 Sep 30, 2023
Q2 2023 -38.8 -139 -139% Apr 1, 2023 Jun 30, 2023
Q1 2023 -105 -38.1 -57.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 239 +274 Oct 1, 2022 Dec 31, 2022
Q3 2022 21.9 +84 Jul 1, 2022 Sep 30, 2022
Q2 2022 99.8 +182 Apr 1, 2022 Jun 30, 2022
Q1 2022 -66.7 +90.7 +57.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -35.5 -409 -109% Oct 1, 2021 Dec 31, 2021
Q3 2021 -62 Jul 1, 2021 Sep 30, 2021
Q2 2021 -82 Apr 1, 2021 Jun 30, 2021
Q1 2021 -157 Jan 1, 2021 Mar 31, 2021
Q4 2020 374 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.